Doctor profile · Federal record
Dr. JAMES CHOE, MD
Specialist (CMS: ENDOCRINOLOGY) · Endocrinology, Diabetes & Metabolism Physician · Internal Medicine Physician · DEL CITY, OK
- NPI 1093075707
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 14 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1221 S SUNNYLANE RD
DEL CITY, OK 731153018
(405) 677-2424
Credentials & registration
- NPI registered
- May 2012 — 14 yrs on file
- Profile last updated
- February 10, 2022
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Oklahoma #29298
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093075707. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,070
Distinct HCPCS
10
Medicare allowed
$188,347
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,033 | 405 | $117 | |
83036 |
Hemoglobin a1c level | 570 | 261 | $9 | |
80053 |
Blood test, comprehensive group of blood chemicals | 391 | 252 | $10 | |
84443 |
Blood test, thyroid stimulating hormone (tsh) | 373 | 246 | $16 | |
80061 |
Blood test, lipids (cholesterol and triglycerides) | 362 | 236 | $13 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 344 | 226 | $8 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 302 | 122 | $32 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 154 | 122 | $82 | |
36415 |
Insertion of needle into vein for collection of blood sample | 80 | 80 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 79 | 50 | $0 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 214. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$1,556
Transactions
74
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 16 | $361.29 | |
| Dexcom, Inc. | 11 | $180.92 | |
| Xeris Pharmaceuticals, Inc. | 7 | $152.82 | |
| Insulet Corporation | 6 | $135.87 | |
| Novo Nordisk Inc | 7 | $116.07 | |
| Abbott Laboratories | 5 | $95.02 | |
| Tandem Diabetes Care, Inc. | 4 | $90.87 | |
| Ascensia Diabetes Care Us Inc. | 4 | $86.74 | |
| Corcept Therapeutics | 4 | $74.02 | |
| ABBVIE INC. | 2 | $45.30 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41.21 | |
| Mannkind Corporation | 2 | $30.87 | |
| Exact Sciences Corporation | 2 | $30.70 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $26.68 | |
| Amgen Inc. | 1 | $25.30 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,515
Patients
531
Total drug cost
$671,510
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 253 | 89 | $4,343 |
| Ozempic (Semaglutide) | Brand | 183 | 56 | $243,838 |
| Trulicity (Dulaglutide) | Brand | 128 | 34 | $215,446 |
| Metformin Hcl | Generic | 127 | 50 | $1,356 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 111 | 34 | $2,189 |
| Jardiance (Empagliflozin) | Brand | 109 | 34 | $122,427 |
| Atorvastatin Calcium | Generic | 97 | 40 | $1,439 |
| Glipizide Er (Glipizide) | Brand | 75 | 30 | $1,664 |
| Lisinopril | Generic | 73 | 25 | $902 |
| Gabapentin | Generic | 64 | 23 | $1,452 |